TY  - GEN
AU  - Jerkeman,M
AU  - Anderson,H
AU  - Dictor,M
AU  - Kvaløy,S
AU  - Akerman,M
AU  - Cavallin-Ståhl,E
TI  - Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study
SN  - 0939-5555
PY  - 2004///0920
KW  - ATP Binding Cassette Transporter, Subfamily B, Member 1
KW  - analysis
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Biomarkers
KW  - Bleomycin
KW  - Cohort Studies
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Ki-67 Antigen
KW  - Leucovorin
KW  - Life Tables
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - chemistry
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Neoplasm Proteins
KW  - Neoplastic Stem Cells
KW  - Norway
KW  - epidemiology
KW  - Prednisone
KW  - Prognosis
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Risk Factors
KW  - Survival Analysis
KW  - Sweden
KW  - Treatment Outcome
KW  - Tumor Suppressor Protein p53
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00277-004-0855-x
ER  -